Table 1 Basic characteristics of study participants in the discovery and replication stage
| Â | Discovery stage in DFTJ cohort | Replication stage in CKB cohort | |||||||
|---|---|---|---|---|---|---|---|---|---|
Variablesa | Controls (n = 751) | Cases (n = 751) | P valueb | Controls (n = 476) | Cases (n = 476) | P valueb | |||
Basic characteristics | |||||||||
 Age, years | 64.84 ± 7.20 | 64.93 ± 7.16 | – | 49.79 ± 7.22 | 50.97 ± 7.62 | – | |||
 Male, n (%) | 376 (50.07) | 376 (50.07) | – | 267 (56.09) | 267 (56.09) | – | |||
 BMI, kg/m2 | 23.93 ± 3.21 | 24.79 ± 3.32 | <0.001 | 23.34 ± 3.24 | 23.95 ± 3.70 | 0.01 | |||
 Current smokers, n (%) | 135 (17.98) | 164 (21.84) | 0.11 | 101 (21.22) | 115 (24.16) | 0.07 | |||
 Current drinkers, n (%) | 216 (28.76) | 217 (28.89) | 0.89 | 92 (19.33) | 70 (14.71) | 0.06 | |||
Estimated cell type proportions | |||||||||
 CD8+ T cell, % | 0.09 ± 0.05 | 0.09 ± 0.04 | 0.94 | 0.05 ± 0.04 | 0.06 ± 0.04 | <0.001 | |||
 CD4+ T cell, % | 0.10 ± 0.04 | 0.10 ± 0.05 | 0.04 | 0.11 ± 0.04 | 0.09 ± 0.05 | <0.001 | |||
 NK cell, % | 0.10 ± 0.05 | 0.10 ± 0.04 | 0.003 | 0.13 ± 0.06 | 0.12 ± 0.06 | 0.001 | |||
 B cell, % | 0.03 ± 0.02 | 0.03 ± 0.03 | 0.05 | 0.03 ± 0.02 | 0.03 ± 0.02 | 0.01 | |||
 Monocyte, % | 0.06 ± 0.03 | 0.07 ± 0.02 | 0.74 | 0.07 ± 0.03 | 0.07 ± 0.03 | 0.51 | |||
 Neutrophil, % | 0.55 ± 0.08 | 0.55 ± 0.08 | 0.99 | 0.61 ± 0.08 | 0.63 ± 0.09 | 0.01 | |||
Diagnosis | |||||||||
 Hypertension, n (%) | 438 (58.32) | 555 (73.90) | <0.001 | 141 (29.62) | 254 (53.36) | <0.001 | |||
 Dyslipidemia, n (%) | 283 (37.68) | 391 (52.06) | <0.001 | 96 (20.17) | 127 (26.68) | 0.02 | |||
 Diabetes, n (%) | 151 (20.11) | 226 (30.09) | <0.001 | 22 (4.62) | 46 (9.66) | 0.003 | |||